These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12442626)

  • 21. Gene therapy in the neuroendocrine system.
    Hereñú CB; Morel GR; Bellini MJ; Reggiani PC; Sosa YE; Brown OA; Goya RG
    Front Horm Res; 2006; 35():135-142. PubMed ID: 16809929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroendocrine disorders of the gut.
    Yee LF; Mulvihill SJ
    West J Med; 1995 Nov; 163(5):454-62. PubMed ID: 8533409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Undernutrition and pituitary function: relevance to the pathophysiology of some neuroendocrine alterations of anorexia nervosa.
    Müller EE; Locatelli V
    J Endocrinol; 1992 Mar; 132(3):327-9. PubMed ID: 1564417
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinically nonfunctioning pituitary adenomas.
    Snyder PJ
    Endocrinol Metab Clin North Am; 1993 Mar; 22(1):163-75. PubMed ID: 8449186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular targets in pituitary tumours.
    Heaney AP; Melmed S
    Nat Rev Cancer; 2004 Apr; 4(4):285-95. PubMed ID: 15057288
    [No Abstract]   [Full Text] [Related]  

  • 26. Brain and cardiovascular diseases: common neurogenic background of cardiovascular, metabolic and inflammatory diseases.
    Szczepanska-Sadowska E; Cudnoch-Jedrzejewska A; Ufnal M; Zera T
    J Physiol Pharmacol; 2010 Oct; 61(5):509-21. PubMed ID: 21081794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study.
    Vergès B; Boureille F; Goudet P; Murat A; Beckers A; Sassolas G; Cougard P; Chambe B; Montvernay C; Calender A
    J Clin Endocrinol Metab; 2002 Feb; 87(2):457-65. PubMed ID: 11836268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Neuroendocrine regulation of adenohypophysis function in adenomas operated on by cryogenic hypophysectomy].
    Balabolkin MI; Kandel' EI; Gerasimov GA; Magomedova ZB
    Sov Med; 1987; (4):39-41. PubMed ID: 3603184
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of surgery and radiotherapy on visual and endocrine function in nonfunctioning pituitary adenomas.
    Colao A; Cerbone G; Cappabianca P; Ferone D; Alfieri A; Di Salle F; Faggiano A; Merola B; de Divitiis E; Lombardi G
    J Endocrinol Invest; 1998 May; 21(5):284-90. PubMed ID: 9648049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of pituitary function in the presence of pituitary adenomas.
    Perria C; Barreca T; Capitanio GL; Indiveri F; Masturzo P; Rolandi E; Polleri A
    J Neurosurg Sci; 1974; 18(4):255-62. PubMed ID: 4619630
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of prolonged LH-releasing hormone administration on gonadotropin response in patients with hypothalamic and pituitary tumors.
    Hashimoto T; Miyai K; Uozumi T; Mori S; Watanabe M
    J Clin Endocrinol Metab; 1975 Oct; 41(4):712-6. PubMed ID: 1100643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cushing's disease and basophilic microadenomas.
    Daughaday WH
    N Engl J Med; 1984 Apr; 310(14):919-20. PubMed ID: 6321989
    [No Abstract]   [Full Text] [Related]  

  • 33. The integration of stress by the hypothalamus, amygdala and prefrontal cortex: balance between the autonomic nervous system and the neuroendocrine system.
    Buijs RM; Van Eden CG
    Prog Brain Res; 2000; 126():117-32. PubMed ID: 11105644
    [No Abstract]   [Full Text] [Related]  

  • 34. Selective roles for the PC2 processing enzyme in the regulation of peptide neurotransmitter levels in brain and peripheral neuroendocrine tissues of PC2 deficient mice.
    Miller R; Toneff T; Vishnuvardhan D; Beinfeld M; Hook VY
    Neuropeptides; 2003 Jun; 37(3):140-8. PubMed ID: 12860111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypothalamic and neuroendocrine changes in Huntington's disease.
    Hult S; Schultz K; Soylu R; Petersén A
    Curr Drug Targets; 2010 Oct; 11(10):1237-49. PubMed ID: 20594177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonsecreting pituitary tumors.
    Klibanski A
    Endocrinol Metab Clin North Am; 1987 Sep; 16(3):793-804. PubMed ID: 3319603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapy of aggressive pituitary tumors.
    Colao A; Grasso LF; Pivonello R; Lombardi G
    Expert Opin Pharmacother; 2011 Jul; 12(10):1561-70. PubMed ID: 21434849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective excision of adenomas originating in or extending into the pituitary stalk with preservation of pituitary function.
    Mason RB; Nieman LK; Doppman JL; Oldfield EH
    J Neurosurg; 1997 Sep; 87(3):343-51. PubMed ID: 9285597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Luteinizing hormone-releasing hormone (LHRH) receptors in the neuroendocrine-immune network. Biochemical bases and implications for reproductive physiopathology.
    Marchetti B; Gallo F; Farinella Z; Romeo C; Morale MC
    Ann N Y Acad Sci; 1996 Apr; 784():209-36. PubMed ID: 8651571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioregulatory role of the kallikrein-kinin system in the normal pituitary gland and its tumours.
    Jones TH; Figueroa CD; Bhoola KD
    Acta Endocrinol (Copenh); 1992 Dec; 127(6):481-4. PubMed ID: 1492535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.